What is Zacks Research’s Estimate for SRPT Q2 Earnings?
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Investment analysts at Zacks Research issued their Q2 2025 earnings estimates for Sarepta Therapeutics in a research report issued to clients and investors on Monday, May 26th. Zacks Research analyst S. Ganoria expects that the biotechnology company will earn ($0.41) per share for the quarter. The consensus […]
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) – Investment analysts at Zacks Research issued their Q2 2025 earnings estimates for Sarepta Therapeutics in a research report issued to clients and investors on Monday, May 26th. Zacks Research analyst S. Ganoria expects that the biotechnology company will earn ($0.41) per share for the quarter. The consensus […]
